Related Experiment Video

Updated: May 10, 2026

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
12:48

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

Canadian Journal of Ophthalmology Lecture: translational research advances in glaucoma neuroprotection

James C Tsai1

  • 1Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Conn, USA. james.tsai@yale.edu

Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|June 18, 2013
PubMed

Insights

Glaucoma, a central nervous system disease, requires novel therapies independent of intraocular pressure. Future treatments may involve neuroprotection and sustained drug delivery for revolutionary glaucoma management.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Pharmacology

Background:

  • Glaucoma is increasingly recognized as a neurodegenerative disease affecting the central nervous system.
  • Current glaucoma treatments primarily focus on reducing intraocular pressure, which may not address all disease mechanisms.

Purpose of the Study:

  • To highlight the need for intraocular pressure-independent therapies for glaucoma.
  • To emphasize the critical role of sustained drug delivery in advancing glaucoma treatment.
  • To explore the potential of neuroprotection and neuroregeneration in developing revolutionary glaucoma therapies.

Main Methods:

  • This study is a conceptual review and synthesis of current research trends.
  • It integrates findings from clinical and basic science research in glaucoma.
  • Focuses on the translational potential of neuroprotective strategies.

Main Results:

  • Developing therapies independent of intraocular pressure is crucial for glaucoma management.
  • Sustained drug delivery systems offer promising avenues for advanced glaucoma treatment.
  • Translational research in neuroprotection holds the key to future revolutionary treatments like neuroregeneration.

Conclusions:

  • A paradigm shift towards neuroprotective and intraocular pressure-independent therapies is essential for glaucoma.
  • Enhanced collaboration between clinical and basic research is vital for innovation.
  • Neuroregeneration represents a potential future frontier for treating glaucoma effectively.

More Related Videos

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...